These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Will vaginal microbicides solve the HIV problem in Africa? Muula AS Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863 [No Abstract] [Full Text] [Related]
3. Trials of two microbicides to be launched in Africa. Pincock S BMJ; 2004 Apr; 328(7443):786. PubMed ID: 15070623 [No Abstract] [Full Text] [Related]
4. Challenges of introducing vaginal microbicides in India. Joshi S; Kulkarni V; Paranjape R; Chandhiok N Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395 [No Abstract] [Full Text] [Related]
5. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials. Abdool Karim SS Future Microbiol; 2010 Apr; 5(4):527-9. PubMed ID: 20353292 [No Abstract] [Full Text] [Related]
6. A second chance for microbicides. Baleta A Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853 [No Abstract] [Full Text] [Related]
7. Potential of vaginal microbicides in HIV control. Stone A J R Soc Med; 2004 Mar; 97(3):158. PubMed ID: 14996989 [No Abstract] [Full Text] [Related]
8. Microbicide research already benefiting thousands--experts. Bateman C S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283 [No Abstract] [Full Text] [Related]
9. First real success for anti-HIV gel: a new start for HIV microbicides? Ariën KK; Vanham G Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683 [No Abstract] [Full Text] [Related]
10. After microbicide failures, hope that antiviral approach will gel. Padma TV Nat Med; 2008 Apr; 14(4):354. PubMed ID: 18391925 [No Abstract] [Full Text] [Related]
11. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109 [TBL] [Abstract][Full Text] [Related]
12. Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides. Bisika T East Afr J Public Health; 2009 Aug; 6(2):223-5. PubMed ID: 20000034 [No Abstract] [Full Text] [Related]
13. Seaweed produces vaginal gel. AIDS Patient Care STDS; 2001 Feb; 15(2):105-6. PubMed ID: 11558458 [No Abstract] [Full Text] [Related]
14. Microbicides may be ready. AIDS Patient Care STDS; 2002 May; 16(5):243. PubMed ID: 12055033 [No Abstract] [Full Text] [Related]
15. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women. Olsen ML; Cwiak CA; Koudelka C; Jensen JT Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444 [TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS. At last, vaginal gel scores victory against HIV. Cohen J Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914 [No Abstract] [Full Text] [Related]
17. Microbicides 2000: report of an international conference, 13-16 March, Washington DC. Berer M Reprod Health Matters; 2000 May; 8(15):126-31. PubMed ID: 11424260 [TBL] [Abstract][Full Text] [Related]
18. Microbicides 2000 conference. Welcoming remarks. The global need for microbicides. Wainberg MA AIDS; 2001 Feb; 15 Suppl 1():S1-2. PubMed ID: 11228106 [No Abstract] [Full Text] [Related]
19. The future of HIV microbicides: challenges and opportunities. Garg AB; Nuttall J; Romano J Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141 [TBL] [Abstract][Full Text] [Related]
20. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents. Joanis CL; Hart CW AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]